CUHK Medicine Ranks Global No. 2
Analysis based on 15 articles · First reported Jun 16, 2026 · Last updated Jun 30, 2026
The high ranking of University of Hong Kong's Faculty of Medicine (CU Medicine) in Gastroenterology & Hepatology could attract more international students and research funding, potentially boosting the local healthcare and biotechnology sectors. This recognition also enhances the global reputation of Hong Kong as a hub for medical research and innovation.
University of Hong Kong's Faculty of Medicine (CU Medicine) has been ranked No. 2 globally in Gastroenterology & Hepatology by U.S. News & World Report for the 2026-27 'Best Global Universities Subject Rankings', maintaining a top-three position for four consecutive editions. The faculty also holds Asia's No. 1 spot in Gastroenterology & Hepatology, Endocrinology & Metabolism, and Clinical Medicine. This recognition is attributed to CU Medicine's pioneering research in gut microbiome, non-invasive diagnostics, endoluminal robotics for GI cancers, and its leadership in international initiatives like The Lancet Commission on liver cancer. Professor Philip Chiu, Dean of Medicine at University of Hong Kong, emphasized the faculty's commitment to continued medical advancement and translation of frontier research.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard